View of Efficacy and safety of secukinumab in the treatment of chronic plaque psoriasis: A 52-weeks follow up study

Return to Issue Details Efficacy and safety of secukinumab in the treatment of chronic plaque psoriasis: A 52-weeks follow up study Download Download PDF